Re: "Inhibition of medullary thyroid carcinoma (MTC) cell proliferation and RET phosphorylation by tyrosine kinase inhibitors" [2] (multiple letters)

Surgery

Volumn 135, Issue 2, 2004, Pages 240-241

  Menacho, Ivan Plaza ^a   De Groot, Jan Willem ^a   Links, Thera ^a   Plukker, John ^a   Eggen, Bart J L ^a   Hofstra, Robert ^a   Moley, Jeffrey F ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; GELDANAMYCIN; GENISTEIN; IMATINIB; PROTEIN RET; PROTEIN TYROSINE KINASE INHIBITOR; STEM CELL FACTOR; STI 1571;

CANCER GROWTH; CANCER INHIBITION; CANCER RESEARCH; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; DRUG RESEARCH; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; GASTROINTESTINAL STROMAL TUMOR; HUMAN; IMMUNOPRECIPITATION; LETTER; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; THYROID MEDULLARY CARCINOMA; WESTERN BLOTTING;

EID: 1642479288     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2003.11.003     Document Type: Letter

References (1)

1. A. Flexner Medical education in the United States and Canada—A report to the Carnegie Foundation for the Advancement of Teaching 1910 The Carnegie Foundation for the Advancement of Teaching New York 50